Bulletin
Investor Alert

Assertio Holdings Inc.

NAS: ASRT

GO
/marketstate/country/us

Market closed

/zigman2/quotes/200485471/composite

$

0.67

Change

-0.02 -2.95%

Volume

Volume 673,368

Sep 23, 2020, 4:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200485471/composite

Previous close

$ 0.69

$ 0.67

Change

-0.02 -2.95%

Day low

Day high

$0.66

$0.71

Open
Open: 0.69

52 week low

52 week high

$0.55

$1.71

Open

Market cap

$74.34M

Average volume

689,522

P/E ratio

N/A

Rev. per Employee

$2.69M

EPS

-2.37

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/asrt

MarketWatch News on ASRT

  1. Here are the stocks that have soared and sunk the most in 2019

    11:21 a.m. Oct. 2, 2019

    - Philip van Doorn

  2. Trump Calls Out Pfizer, Puts Drug Prices Back in Spotlight

    1:43 p.m. July 9, 2018

    - Barrons Blogs

  3. Carl Icahn Thinks AFSI Shares Are Too Cheap at $13.50

    8:00 p.m. May 25, 2018

    - Barron's Online

  4. Biotech ETFs fall, led by Celgene

    1:15 p.m. Feb. 28, 2018

    - Ryan Vlastelica

  5. DepoMed stock price target raised to $8 from $6 at UBS

    10:24 a.m. Dec. 7, 2017

    - Tomi Kilgore

  6. Depomed farms out Nucynta sales, will lay off 40% of company

    6:03 p.m. Dec. 4, 2017

    - Jeremy C. Owens

  7. Depomed to reduce staff by 40%, move headquarters out of California

    5:33 p.m. Dec. 4, 2017

    - MarketWatch

  8. Depomed will eliminate sales staff for Nucynta along with advertising

    5:32 p.m. Dec. 4, 2017

    - MarketWatch

  9. Collegium, Depomed strike deal for Nucynta sales

    5:31 p.m. Dec. 4, 2017

    - MarketWatch

  10. Collegium agrees to commercialize Depomed's Nucynta painkiller

    5:32 p.m. Dec. 4, 2017

    - MarketWatch

  11. Depomed trading halted for pending news

    5:26 p.m. Dec. 4, 2017

    - MarketWatch

  12. DepoMed stock price target cut to $51 from $66 at UBS

    9:54 a.m. Aug. 15, 2017

    - Tomi Kilgore

  13. DepoMed Q2 rev. $100.4 million vs. expectations $100.1 million

    4:14 p.m. Aug. 7, 2017

    - Claudia Assis

  14. DepoMed Q2 adj. EPS 8 cents vs. expectations 9 cents

    4:15 p.m. Aug. 7, 2017

    - Claudia Assis

  15. DepoMed shares down more than 8% following company results

    4:12 p.m. Aug. 7, 2017

    - Claudia Assis

  16. Stock winners and losers — Nvidia rockets and Yelp tumbles

    11:33 a.m. May 10, 2017

    - Philip van Doorn

  17. Depomed shares down 13% after earnings miss

    4:38 p.m. May 9, 2017

    - Claudia Assis

  18. Elliott Associates Sees an Opening for Roadrunner Transportation

    11:59 p.m. April 7, 2017

    - Barron's Online

  19. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/asrt

Other News on ASRT

  1. More on Assertio Therapeutics Q2 earnings

    3:06 p.m. Aug. 7, 2020

    - Seeking Alpha

  2. Summers Value Partners Q2 2020 Investor Letter

    1:00 p.m. July 21, 2020

    - Seeking Alpha

  3. Assertio (ASRT) Beats Q1 Earnings and Revenue Estimates

    10:35 a.m. May 11, 2020

    - Zacks.com

  4. 10-Q: ASSERTIO THERAPEUTICS, INC

    10:12 a.m. May 11, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  5. Assertio +48% on completion of asset sales

    9:06 a.m. May 11, 2020

    - Seeking Alpha

  6. Assertio Therapeutics to merge with Zyla Life Sciences

    9:58 p.m. March 16, 2020

    - Seeking Alpha

  7. Assertio launches tender offer for outstanding convertible debt

    12:15 p.m. March 11, 2020

    - Seeking Alpha

  8. 10-K: ASSERTIO THERAPEUTICS, INC

    8:25 a.m. March 10, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  9. Assertio (ASRT) Reports Q4 Loss, Tops Revenue Estimates

    5:55 p.m. March 9, 2020

    - Zacks.com

  10. Assertio Q4 top line up 39%

    4:47 p.m. March 9, 2020

    - Seeking Alpha

  11. Loading more headlines...
/news/pressrelease/company/us/asrt

Press Releases on ASRT

  1. Assertio Reports Second Quarter 2020 Financial Results

    6:02 a.m. Aug. 7, 2020

    - GlobeNewswire

  2. Assertio Reports Second Quarter 2020 Financial Results

    6:02 a.m. Aug. 7, 2020

    - GlobeNewswire

  3. Assertio Completed Merger with Zyla Life Sciences

    8:48 a.m. May 20, 2020

    - PR Newswire - PRF

  4. Assertio Therapeutics Announces First-Quarter 2020 Results

    8:00 a.m. May 11, 2020

    - GlobeNewswire

  5. Assertio Therapeutics Announces First-Quarter 2020 Results

    8:00 a.m. May 11, 2020

    - GlobeNewswire

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.